Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5368630> ?p ?o }
Showing triples 1 to 45 of
45
with 100 triples per page.
- Q5368630 subject Q7334142.
- Q5368630 subject Q7486806.
- Q5368630 subject Q8210706.
- Q5368630 subject Q8852383.
- Q5368630 subject Q8919936.
- Q5368630 abstract "Elzasonan (CP-448,187) is a selective 5-HT1B and 5-HT1D receptor antagonist that was under development by Pfizer for the treatment of depression but was discontinued, possibly due to poor efficacy. By preferentially blocking 5-HT1B and 5-HT1D autoreceptors, elzasonan is thought to enhance serotonergic innervations originating from the raphe nucleus, thereby improving signaling to limbic regions like the hippocampus and prefrontal cortex and ultimately resulting in antidepressant effects.".
- Q5368630 atcPrefix "none".
- Q5368630 casNumber "220322-05-4".
- Q5368630 fdaUniiCode "933PJL964R".
- Q5368630 iupacName "4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one".
- Q5368630 pubchem "19544192".
- Q5368630 thumbnail Elzasonan_structure.svg?width=300.
- Q5368630 wikiPageWikiLink Q12746850.
- Q5368630 wikiPageWikiLink Q18027423.
- Q5368630 wikiPageWikiLink Q18027426.
- Q5368630 wikiPageWikiLink Q18680.
- Q5368630 wikiPageWikiLink Q192560.
- Q5368630 wikiPageWikiLink Q2061493.
- Q5368630 wikiPageWikiLink Q206921.
- Q5368630 wikiPageWikiLink Q410943.
- Q5368630 wikiPageWikiLink Q417749.
- Q5368630 wikiPageWikiLink Q42844.
- Q5368630 wikiPageWikiLink Q4590759.
- Q5368630 wikiPageWikiLink Q48360.
- Q5368630 wikiPageWikiLink Q4914025.
- Q5368630 wikiPageWikiLink Q5514387.
- Q5368630 wikiPageWikiLink Q7334142.
- Q5368630 wikiPageWikiLink Q7486806.
- Q5368630 wikiPageWikiLink Q76560.
- Q5368630 wikiPageWikiLink Q8210706.
- Q5368630 wikiPageWikiLink Q8852383.
- Q5368630 wikiPageWikiLink Q8919936.
- Q5368630 atcPrefix "none".
- Q5368630 casNumber "220322".
- Q5368630 iupacName "4".
- Q5368630 pubchem "19544192".
- Q5368630 unii "933".
- Q5368630 type ChemicalSubstance.
- Q5368630 type Drug.
- Q5368630 type ChemicalObject.
- Q5368630 type Thing.
- Q5368630 type Q8386.
- Q5368630 comment "Elzasonan (CP-448,187) is a selective 5-HT1B and 5-HT1D receptor antagonist that was under development by Pfizer for the treatment of depression but was discontinued, possibly due to poor efficacy. By preferentially blocking 5-HT1B and 5-HT1D autoreceptors, elzasonan is thought to enhance serotonergic innervations originating from the raphe nucleus, thereby improving signaling to limbic regions like the hippocampus and prefrontal cortex and ultimately resulting in antidepressant effects.".
- Q5368630 label "Elzasonan".
- Q5368630 depiction Elzasonan_structure.svg.